Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.

Clostridium difficile

Presented byNate Smith, MD, MPHCarole Yeung, RN CIC

2

Outline

• Epidemiology

• Treatment

• Prevention

3

What is Clostridium difficile?

• Anaerobic spore-forming bacillus• Present in the soil and environment• Produces two toxins – Toxins A and B• Common cause of antibiotic associated diarrhea

(AAD). 15 – 25 % all episodes of AAD• Health care settings are major reservoirs• 20 – 40% hospital patients colonized• 4 – 20% LTCF residents colonized

4

What are C. difficile-associated diseases (CDAD)

• Pseudomembranous colitis (PMC)

• Toxic megacolon

• Perforations of the colon

• Sepsis

• Death (rarely) but increasing!

5

CDAD-related deaths - Arkansas

0

10

20

30

40

50

60

DE

AT

HS

1999 2000 2001 2002 2003 2004 2005*

*2005 data incomplete

7

Symptoms of CDAD

• Watery diarrhea• Fever• Loss of appetite• Abdominal pain• Nausea and vomiting• Severe cases: increase WBC and/or creatinine • Can occur up to 8 weeks after antimicrobial

therapy

8

Which patients are at increased risk for CDAD?

• Antibiotic exposure – clindamycin, penicillins, cephalosporins, floroquinolones

• Gastrointestinal surgery

• Length of stay in healthcare settings

• A serious underlying illness

• Immunocompromising conditions

• Advanced age

9

C. difficile colonization

• Patient exhibits no clinical symptoms

• Patient tests positive for C. difficile organism and/or its toxin

• More common than CDAD

10

C. difficile disease (CDAD)

• Patient exhibits clinical symptoms

• Patient tests positive for C. difficile organism and/or its toxin

11

Laboratory Tests for CDAD

• Stool culture

• Antigen detection

• Toxin testing

12

C. difficile Transmission

• C. difficile spores are shed in feces

• Any surface, device or material that becomes contaminated with feces may serve as a reservoir

• Transferred by hands of healthcare personnel

13

Treatment

• Discontinue antibiotics if feasible

• Metronidazole orally for 10 days

• Vancomycin orally

• Relapses are common

• Repeat testing NOT recommended

• NO antiperistalic agents

14

Infection Control Preventive Methods

• Use antibiotics judiciously

• Early diagnosis

• Contact precautions for patients with CDAD

• Hand hygiene

• Environmental cleaning and disinfection

15

Contact Precautions

• Private room or cohort

• Gloves

• Gowns

• Dedicated patient care equipment

16

Hand Hygiene

Soap and water for at least 15 seconds:

• Wet hands under running water

• Apply soap

• Good friction rub for 15 seconds

• Rinse hands

• Dry well with paper towel

30

Cleaning and Disinfection

• Clean/disinfect environmental surfaces and reusable items

• Hospital disinfectant

• 1:10 bleach

31

Discontinuing Precautions

• NO diarrhea. NO precautions!

• Repeat testing NOT recommended

32

Transfer of Patients

• Notify receiving facility if patient has a history of C. difficile

• Observe for recurrence

33

References

• SHEA Position Paper CDAD, ICHE 1995

• SHEA Position Paper C. difficile in LTCF for the elderly, ICHE 2002

34

QUESTIONS?

Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.

Documents

Transcript of Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.